← All Spruce Biosciences, INC filings

Spruce Biosciences, INC 8-K filings

NASDAQ
SPRB
Spruce Biosciences, INC
8-K: Spruce Biosciences Announces Full Year 2023 Results, Provides Clinical Trial Updates and Implements Cost Reduction Plan
Spruce Biosciences reported its 2023 financial results, provided updates on its clinical trials, and announced a cost reduction plan including a workforce reduction and termination of a clinical trial.